Evidence map›Paper›PMID 31801472›Full record

ArticleBMC bioinformatics2019

Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures.

Alexander M Sevy, Cinque Soto, Robin G Bombardi, Jens Meiler, James E Crowe

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. T Cell Receptor Repertoires AcquiredFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander M SevyChemical & Physical Biology Program, Vanderbilt University, Nashville, TN, 37235, USA.
Cinque SotoVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Robin G BombardiVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Jens MeilerChemical & Physical Biology Program, Vanderbilt University, Nashville, TN, 37235, USA.
James E CroweChemical & Physical Biology Program, Vanderbilt University, Nashville, TN, 37235, USA. james.crowe@vumc.org.ORCID http://orcid.org/0000-0002-0049-1079

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Structure based design of antibodies and vaccinesU19AI117905 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SCHIEF, WILLIAM R. · 2015 to 2019
$12.0M
NIAID NIH HHS U19 AI117905NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

backgroundAdvances in next-generation sequencing (NGS) of antibody repertoires have led to an explosion in B cell receptor sequence data from donors with many different disease states. These data have the potential to detect patterns of immune response across populations. However, to this point it has been difficult to interpret such patterns of immune response between disease states in the absence of functional data. There is a need for a robust method that can be used to distinguish general patterns of immune responses at the antibody repertoire level.

resultsWe developed a method for reducing the complexity of antibody repertoire datasets using principal component analysis (PCA) and refer to our method as "repertoire fingerprinting." We reduce the high dimensional space of an antibody repertoire to just two principal components that explain the majority of variation in those repertoires. We show that repertoires from individuals with a common experience or disease state can be clustered by their repertoire fingerprints to identify common antibody responses.

conclusionsOur repertoire fingerprinting method for distinguishing immune repertoires has implications for characterizing an individual disease state. Methods to distinguish disease states based on pattern recognition in the adaptive immune response could be used to develop biomarkers with diagnostic or prognostic utility in patient care. Extending our analysis to larger cohorts of patients in the future should permit us to define more precisely those characteristics of the immune response that result from natural infection or autoimmunity.

Indexed as

Principal Component AnalysisAdultAntibodiesCohort StudiesFetal BloodHigh-Throughput Nucleotide SequencingHIV InfectionsHumansInfluenza, HumanMiddle AgedVaccinationAntibodiesAntibody sequencingImmune repertoire analysisPrincipal component analysisRepertoire dissimilarity index

Identifiers

PMID31801472
PMCPMC6894320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.